A new trading day began on Friday, with Fractyl Health Inc (NASDAQ: GUTS) stock price down -4.76% from the previous day of trading, before settling in for the closing price of $2.1. GUTS’s price has ranged from $0.82 to $3.03 over the past 52 weeks.
During the last 5-year period, the sales drop of Healthcare Sector giant was -12.32%. Meanwhile, its annual earnings per share averaged 0.74%. With a float of $113.53 million, this company’s outstanding shares have now reached $132.22 million.
Fractyl Health Inc (GUTS) Insider Activity
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Fractyl Health Inc is 17.16%, while institutional ownership is 57.63%. The most recent insider transaction that took place on Dec 04 ’25, was worth 19,999. In this transaction Chief Executive Officer of this company bought 10,416 shares at a rate of $1.92, taking the stock ownership to the 501,745 shares. Before that another transaction happened on Mar 14 ’25, when Company’s Director bought 17,901 for $1.28, making the entire transaction worth $22,980. This insider now owns 17,901 shares in total.
Fractyl Health Inc (GUTS) Earnings and Forecasts
In its latest quarterly report, released on 12/31/2024, the company reported earnings of -0.52 per share, which was $0.1 lower than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.16 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 0.74% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 26.27% during the next five years compared to -12.32% drop over the previous five years of trading.
Fractyl Health Inc (NASDAQ: GUTS) Trading Performance Indicators
Here are Fractyl Health Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 4.27.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.27, a number that is poised to hit -0.18 in the next quarter and is forecasted to reach -0.69 in one year’s time.
